Table 4.
Relationships between clinicopathological characteristics and skip metastasis
| Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|
| (−) | (+) | P value | Adjusted OR (95% CI) | P value | |
| Sex | 0.411 | ||||
| Female | 1157 (70.8%) | 103 (74.1%) | |||
| Male | 477 (29.2%) | 36 (25.9%) | |||
| Age | < 0.001* | 2.354 (1.522–3.640) | < 0.001* | ||
| < = 55 | 1200 (86.0%) | 89 (72.4%) | |||
| > 55 | 196 (14.0%) | 34 (27.6%) | |||
| Size (cm) | 0.101 | ||||
| ≤ 1 | 796 (48.7%) | 66 (47.5%) | |||
| 1~2 | 582 (35.6%) | 42 (30.2%) | |||
| > 2 | 256 (15.7%) | 31 (22.3%) | |||
| Location | < 0.001* | 4.295 (2.885–6.395) | < 0.001* | ||
| Upper | 527 (32.3%) | 97 (69.8%) | |||
| Non-upper | 1107 (67.7%) | 42 (30.2%) | |||
| ETE | 338 (20.7%) | 37 (26.6%) | 0.100 | ||
| Multifocality | 283 (17.3%) | 29 (20.9%) | 0.292 | ||
| Hashimoto | 229 (14.0%) | 18 (12.9%) | 0.728 | ||
*Symbol for p < 0.05
ETE extrathyroidal extension, OR odds ratio, CI confidence Interval